CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory systemic sclerosis, with 96% remaining off SSc treatment during follow-up, ...
Please provide your email address to receive an email when new articles are posted on . Patients with systemic sclerosis reported an improved ability to perform daily tasks when receiving ...
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback